...
首页> 外文期刊>Oncology letters >Prediction of long-term survival rates in patients undergoing curative resection for solitary hepatocellular carcinoma
【24h】

Prediction of long-term survival rates in patients undergoing curative resection for solitary hepatocellular carcinoma

机译:孤立肝细胞癌患者治疗切除患者长期存活率的预测

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The present study developed a novel laboratory-based algorithm to predict long-term survival rates in patients undergoing curative resection for solitary hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). The present study included 426 patients with solitary HBV-related HCC who underwent surgery for primary tumors at a single center between 2003 and 2012. Demographic characteristics, laboratory analysis, clinical pathology and immunohistochemistry of topoisomerase II-a and Ki67 were analyzed. A simple prognostic risk calculator was developed using regression coefficients from multivariate models. A prognostic risk calculator incorporating tumor encapsulation, neutrophil-to-lymphocyte ratio, vascular invasion, alpha-fetoprotein level, Edmondson-Steiner classification, Topo II-alpha, prognostic nutritional index and Child-Pugh grade was constructed. The prognostic model demonstrated good discrimination with a C-index prior to adjustment of 0.81 (95% confidence interval: 0.78-0.84) and a bootstrap-corrected C-index of 0.81. Kaplan-Meier curves demonstrated that the probabilities of overall survival rates in the low-risk group were increased compared with those in the high-risk group. The areas under the receiver operating characteristic curve using the method were greater compared with those under the 7th Tumor-Node-Metastasis system and Cancer of the Liver Italian Program scoring system [0.83 vs. 0.62 and 0.77 (P0.001), respectively]. The simple prognostic model of the present study accurately predicted survival rates in patients. Such a prognostic risk calculator for staging patients undergoing curative resection for solitary HBV-related HCC facilitates clinical surveillance and therapy.
机译:本研究开发了一种新的基于实验室的算法,以预测患有孤立性乙型肝炎病毒(HBV)的治疗切除术患者的长期存活率 - 相关的肝细胞癌(HCC)。本研究包括426例孤立性HBV相关的HCC患者,在2003年至2012年期间的单一中心进行初级肿瘤的手术。分析了拓扑异构酶II-A和KI67的人口统计学特性,实验室分析,临床病理学和免疫组织化学。使用来自多变量模型的回归系数开发了简单的预后风险计算器。构建了一种预后风险计算器,构建了肿瘤封装,中性粒细胞对淋巴细胞比,血管侵袭,α-胎儿水平,Edmondson-Steiner分类,Topo II-α,预后营养指数和儿童-Pugh等级。预后模型在调节0.81之前的C型指数表现出良好的识别(95%置信区间:0.78-0.84)和0.81的引导校正的C折射率。 Kaplan-Meier曲线表明,与高风险组中,低风险组总存活率的概率增加。与第7次肿瘤节点转移系统和肝脏意大利计划评分系统的癌症下的那些相​​比,使用该方法的接收器操作特征曲线的区域进行了更大的比较[0.83 vs.0.62和0.77(P <0.001)]。本研究的简单预后模型准确地预测了患者的存活率。这种预后风险计算器用于接受孤立HBV相关的HCC治疗治疗患者的分期患者促进了临床监测和治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号